Until today only four Class I evidence based treatment options exist, treatment on stroke unit, intravenous tissue plasminogen activator within 4.5 h of stroke onset, decompressive craniotomy in malignant middle cerebral artery infarction, and aspirin within 48 h of stroke onset [8, 9]. This evidence concerns the gene PLAT and stroke disorder.